Diseases · Entity Annotation Prototype (beta)

2articles mentioning diseases

7disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: CSPH ×

CSPH

This disease is selected. Its supporting articles are shown below.

CSPH2

Articles mentioning CSPH

2 articles · page 1 of 1

P4 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis

gutjnl · abstract · 2025-10-06 · 5 matching annotations

86.0%

MASH metabolic dysfunction-associated steatohepatitis NASH CSPH MASH cirrhosis portal hypertension Resmetirom

…trate clinical benefit in MAESTRO-NASH OUTCOMES, an ongoing 845 MASH cirrhosis patient clinical outcome study.…

British Society of Gastroenterology position statement on the American Association for the Study of Liver Disease practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis

flgastro · abstract · 2026-06-05 · 2 matching annotations